BioDot Funding: How Much Did They Raise & Key Investors

How Much Did BioDot Raise?
Funding & Key Investors

BioDot, a manufacturer of automated ultralow volume fluid dispensing systems, has secured $350K in total capital, with its most recent financing round bringing in $350K. This significant strategic investment underscores the company's established position in the market and its ongoing growth trajectory.

What is BioDot?

BioDot

Manufacturing

Test & Measurement Equipment

Industrial Machinery & Equipment

Founded in 1994 and headquartered in Irvine, California, BioDot specializes in automated ultralow volume fluid dispensing systems. The company's offerings cater to a range of applications, including aspirating and dispensing fluids, cell printing, and support for lateral flow assays and microarray technologies. BioDot's deep expertise in precision fluid handling positions it as a key player in the life sciences and medical device manufacturing sectors.

How much funding has BioDot raised?

BioDot has raised a total of $350K across 1 funding round:

2020

Debt

$350K

Debt (2020): $350K with participation from PPP

What's next for BioDot?

The substantial large-scale late-stage funding indicates BioDot is poised for significant expansion and further technological development. This capital infusion is expected to fuel advancements in their automated dispensing solutions, potentially broadening their market reach and enhancing their product portfolio. The company's strategic focus will likely involve scaling operations and solidifying its leadership in precision fluid management for critical scientific and industrial applications.

See full BioDot company page

See More Financial Insights